BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1660221)

  • 1. Prevalence of antibodies to hepatitis C virus in the hemodialysis unit.
    Lin HH; Huang CC; Sheen IS; Lin DY; Liaw YF
    Am J Nephrol; 1991; 11(3):192-4. PubMed ID: 1660221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis.
    Huang CC; Wu MS; Lin DY; Liaw YF
    Perit Dial Int; 1992; 12(1):31-3. PubMed ID: 1311963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units.
    Oguchi H; Miyasaka M; Tokunaga S; Hora K; Ichikawa S; Ochi T; Yamada K; Nagasawa M; Kanno Y; Aizawa T
    Clin Nephrol; 1992 Jul; 38(1):36-43. PubMed ID: 1499167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of hepatitis C virus antibodies in hospital personnel and the general population].
    Abb J
    Offentl Gesundheitswes; 1991 Apr; 53(4):158-60. PubMed ID: 1714067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis C infection in a hemodialysis unit.
    Colombo P; Filiberti O; Porcu M; Costantini L; Mangione A; Monzeglio C; Peona C
    Nephron; 1992; 61(3):326-7. PubMed ID: 1323782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors.
    Dentico P; Buongiorno R; Volpe A; Carlone A; Carbone M; Manno C; Proscia F; Pastore G; Schiraldi O
    Clin Nephrol; 1992 Jul; 38(1):49-52. PubMed ID: 1499169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of antibodies to hepatitis C virus in hemodialysis patients.
    Kallinowski B; Theilmann L; Gmelin K; Andrassy K; Deppermann D; Weinel B; Kommerell B
    Nephron; 1991; 59(2):236-8. PubMed ID: 1659672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C infection in a pediatric dialysis population.
    Jonas MM; Zilleruelo GE; LaRue SI; Abitbol C; Strauss J; Lu Y
    Pediatrics; 1992 Apr; 89(4 Pt 2):707-9. PubMed ID: 1313556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
    Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of hepatitis C virus antibodies in hospital personnel].
    Cağatay M; Tülek N; Köksalan H; Mert A
    Mikrobiyol Bul; 1992 Jul; 26(3):242-7. PubMed ID: 1382216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of antibodies to hepatitis C virus in three haemodialysis centres in south-western Poland.
    Hruby Z; Sliwiński J; Molin I; Zalewska M; Knysz B; Czyz W; Steciwko A; Bogucki J; Gładysz A
    Nephrol Dial Transplant; 1993; 8(8):740-3. PubMed ID: 7692355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors.
    Malaguti M; Capece R; Marciano M; Arena G; Luciani MP; Striano M; Biagini M
    Nephron; 1992; 61(3):346. PubMed ID: 1323786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of hepatitis C virus antibodies in hospital personnel.
    Abb J
    Zentralbl Bakteriol; 1991 Jan; 274(4):543-7. PubMed ID: 1650558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan.
    Wu JS; Lu CF; Liu WT; Lin SY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):55-60. PubMed ID: 1657545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus in chronic dialysis patients.
    Natov SN; Pereira BJ
    Minerva Urol Nefrol; 2005 Sep; 57(3):175-97. PubMed ID: 15986016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.